Glenview Trust’s Merck MRK Stock Holding History

Glenview Trust’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$45.3M	Buy	376,892 +9,616	+3%	+$1.11M	0.71%	33
2025 Q4	$38.7M	Sell	367,276 -123	-0%	-$11.5K	0.6%	35
2025 Q3	$30.8M	Sell	367,399 -2,490	-0.7%	-$205K	0.49%	40
2025 Q2	$29.3M	Sell	369,889 -1,637	-0.4%	-$130K	0.51%	42
2025 Q1	$33.3M	Buy	371,526 +29,536	+9%	+$2.76M	0.65%	32
2024 Q4	$34M	Sell	341,990 -14,283	-4%	-$1.47M	0.64%	33
2024 Q3	$40.5M	Buy	356,273 +12,742	+4%	+$1.51M	0.78%	28
2024 Q2	$42.5M	Buy	343,531 +5,159	+2%	+$665K	0.86%	25
2024 Q1	$44.6M	Buy	338,372 +16,549	+5%	+$2.04M	0.96%	23
2023 Q4	$35.1M	Buy	321,823 +2,727	+0.9%	+$283K	0.86%	27
2023 Q3	$32.9M	Buy	319,096 +7,604	+2%	+$820K	0.91%	25
2023 Q2	$35.9M	Buy	311,492 +2,630	+0.9%	+$299K	0.98%	24
2023 Q1	$32.9M	Buy	308,862 +7,612	+3%	+$822K	0.98%	26
2022 Q4	$33.4M	Buy	301,250 +13,410	+5%	+$1.37M	1.11%	24
2022 Q3	$24.8M	Buy	287,840 +11,984	+4%	+$1.07M	0.94%	28
2022 Q2	$25.1M	Buy	275,856 +12,387	+5%	+$1.1M	0.92%	30
2022 Q1	$21.6M	Buy	263,469 +19,367	+8%	+$1.53M	0.7%	42
2021 Q4	$18.7M	Buy	244,102 +692	+0.3%	+$55.1K	0.62%	50
2021 Q3	$18.3M	Buy	243,410 +5,698	+2%	+$433K	0.71%	48
2021 Q2	$18.5M	Buy	237,712 +3,543	+2%	+$264K	0.71%	44
2021 Q1	$17.2M	Buy	234,169 +14,902	+7%	+$1.1M	0.74%	45
2020 Q4	$17.1M	Buy	219,267 +1,382	+0.6%	+$106K	0.8%	40
2020 Q3	$17.2M	Buy	217,885 +3,387	+2%	+$265K	0.89%	34
2020 Q2	$15.8M	Buy	214,498 +20,499	+11%	+$1.54M	0.9%	33
2020 Q1	$14.2M	Buy	193,999 +7,413	+4%	+$583K	0.99%	31
2019 Q4	$16.2M	Buy	186,586 +978	+0.5%	+$80.3K	0.91%	36
2019 Q3	$14.9M	Buy	185,608 +6,048	+3%	+$485K	0.9%	34
2019 Q2	$14.4M	Buy	179,560 +16,475	+10%	+$1.26M	0.89%	33
2019 Q1	$12.9M	Buy	163,085 +13,201	+9%	+$987K	0.83%	35
2018 Q4	$10.9M	Buy	149,884 +17,613	+13%	+$1.24M	0.81%	35
2018 Q3	$8.95M	Buy	132,271 +11,415	+9%	+$727K	0.56%	57
2018 Q2	$7M	Buy	120,856 +32,651	+37%	+$1.84M	0.52%	61
2018 Q1	$4.58M	Buy	88,205 +27,514	+45%	+$1.49M	0.32%	94
2017 Q4	$3.26M	Sell	60,691 -122	-0.2%	-$6.76K	0.22%	104
2017 Q3	$3.72M	Buy	60,813 +3,025	+5%	+$183K	0.27%	104
2017 Q2	$3.53M	Sell	57,788 -502	-0.9%	-$30.6K	0.27%	100
2017 Q1	$3.53M	Buy	58,290 +296	+0.5%	+$18K	0.28%	96
2016 Q4	$3.26M	Buy	+57,994	New	+$3.39M	0.27%	96
2015 Q4	$2.62M	Buy	+52,061	New	+$2.62M	0.27%	93
2014 Q4	$2.46M	Buy	+45,476	New	+$2.53M	0.26%	77
2013 Q4	$2.38M	Buy	+49,722	New	+$2.27M	0.27%	76

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Glenview Trust's MRK Position: Q1 2026 in Review

Glenview Trust increased its Merck (MRK) stake by 2.6% in Q1 2026, buying an estimated $1.11M and bringing the position to 376,892 shares worth $45.3M. The position accounts for 0.71% of the portfolio, ranked #33.

Glenview Trust first reported a position in MRK in Q4 2013 and has held it in 41 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Glenview Trust held 376,892 shares of Merck worth $45.3M as of Q1 2026.
Glenview Trust bought 9,616 Merck shares in Q1 2026, an estimated $1.11M.
Merck made up 0.71% of Glenview Trust's portfolio in Q1 2026, its #33 holding.
Glenview Trust first reported a position in Merck in Q4 2013 and has held it in 41 quarters since.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.